Aveanna Projects $2.57B Revenue, $330M EBITDA for 2026

Aveanna Healthcare Holdings issued forward-looking financial guidance for fiscal year 2026, as reported on May 14, 2026. The home healthcare provider projects full-year revenue to fall between $2.56 billion and $2.58 billion. This top-line forecast is accompanied by an adjusted EBITDA target ranging from $328 million to $332 million. The company also confirmed it is targeting a late second-quarter close for its pending acquisition of Family First, a move expected to contribute to its growth trajectory.

What is Aveanna's 2026 Financial Outlook?

Aveanna's guidance signals management's confidence in its operational strategy and market position. The revenue target, centered at $2.57 billion, represents a significant goal for the company. The forecast for adjusted EBITDA, a key measure of profitability that excludes interest, taxes, depreciation, and amortization, is equally strong. At the midpoint of $330 million, the guidance implies an adjusted EBITDA margin of approximately 12.8%.

This margin is a critical indicator for investors, reflecting the company's ability to convert revenue into profit before accounting for financing and accounting decisions. Achieving this level of profitability depends on efficient cost management, stable reimbursement rates, and successful integration of acquired assets. The narrow range of both the revenue and EBITDA forecasts suggests a high degree of visibility into its business drivers for the coming year.

How Will the Family First Acquisition Impact Operations?

The planned acquisition of Family First is a central component of Aveanna's growth strategy. The company is targeting a close for the transaction in the late second quarter of 2026. Acquisitions in the home healthcare sector are often pursued to expand geographic footprint, add new service lines, or increase patient census in key demographics. Integrating Family First is expected to bolster Aveanna's market presence.

Successful integration will be crucial to realizing the full financial benefits embedded in the 2026 forecast. This involves merging clinical and administrative systems, aligning care protocols, and retaining key personnel from the acquired company. The costs associated with this integration are typically excluded from adjusted EBITDA figures, but the operational execution will directly impact future revenue and profitability. More details on the strategic fit are expected following the deal's close.

What Are the Key Risks to This Forecast?

While the guidance is optimistic, Aveanna faces several industry-wide challenges that could impact its ability to meet these targets. A primary risk is reimbursement pressure from government payers like Medicare and Medicaid, which account for a substantial portion of revenue for home healthcare providers. Any adverse changes to these payment rates could directly compress margins and affect profitability.

A second significant headwind is the persistent labor shortage in the healthcare sector. Attracting and retaining qualified nurses and caregivers is a major operational challenge. Increased labor costs, including higher wages and signing bonuses, could pressure the expense side of the ledger, potentially making the 12.8% adjusted EBITDA margin target more difficult to achieve. The successful integration of Family First also presents its own set of execution risks that must be managed carefully.

How Does This Guidance Position Aveanna?

The 2026 forecast provides a clear benchmark for investors to measure Aveanna's performance against. By issuing specific financial targets, the leadership team creates accountability and sets market expectations. This guidance will likely be used by analysts to update their financial models and valuation targets for the company's stock, which currently has a market capitalization of over $450 million.

The projections position Aveanna as a company focused on a dual strategy of organic growth and strategic acquisitions. The combination of a strong top-line forecast and a double-digit EBITDA margin target suggests a focus on both scale and efficiency. The market's reaction in the coming quarters will depend on the company's ability to execute on its plan, particularly the smooth integration of Family First and navigating the complex labor and reimbursement environment.

Q: What services does Aveanna Healthcare provide?

A: Aveanna Healthcare is a diversified home care provider. Its primary services include private duty nursing for medically complex children and adults, adult day health services, and home health and hospice services. The company also provides medical solutions, including enteral nutrition and respiratory therapy, serving patients across more than 30 states in the U.S.

Q: What is adjusted EBITDA?

A: Adjusted EBITDA is a non-GAAP financial measure that represents earnings before interest, taxes, depreciation, and amortization. It is further adjusted to exclude items that management does not consider to be indicative of ongoing core operating performance. These adjustments can include stock-based compensation, acquisition-related costs, and other non-recurring expenses. It is often used to assess a company's operational profitability and ability to service debt.

Q: Why is the home healthcare market growing?

A: The home healthcare market is expanding due to several factors. Key drivers include an aging U.S. population requiring more long-term care, patient preference for receiving care in the comfort of their home, and the cost-effectiveness of home-based care compared to traditional hospital stays. Technological advancements in remote monitoring and telehealth are also making it easier to deliver complex medical care at home, further fueling sector growth.

Bottom Line

Aveanna's 2026 forecast projects significant growth, contingent on its successful integration of Family First and management of industry-wide cost pressures.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.